Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study
- 30 November 2004
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 46 (2) , 233-245
- https://doi.org/10.1016/j.lungcan.2004.03.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Therapy choices among older patients with lung carcinomaCancer, 2001
- Radiotherapy in the elderlyEuropean Journal of Surgical Oncology, 1998
- Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the NetherlandsAnnals of Oncology, 1996
- Age and the treatment of lung cancer.Thorax, 1996
- Differences in initial treatment patterns and outcomes of lung cancer in the elderlyLung Cancer, 1995
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderlyJAMA, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948